HK1040933A1 - N-取代的氮雜二環烷衍生物在治療中樞神經系統疾病中的應用 - Google Patents

N-取代的氮雜二環烷衍生物在治療中樞神經系統疾病中的應用

Info

Publication number
HK1040933A1
HK1040933A1 HK02102768.4A HK02102768A HK1040933A1 HK 1040933 A1 HK1040933 A1 HK 1040933A1 HK 02102768 A HK02102768 A HK 02102768A HK 1040933 A1 HK1040933 A1 HK 1040933A1
Authority
HK
Hong Kong
Prior art keywords
derivates
nervous system
central nervous
treating diseases
azabicycloalkane
Prior art date
Application number
HK02102768.4A
Other languages
English (en)
Inventor
G‧斯坦納
R‧穆恩紹爾
G‧戈羅斯
M‧特勞特
L‧安格
H-J‧泰申多夫
Original Assignee
巴斯福股份公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 巴斯福股份公司 filed Critical 巴斯福股份公司
Publication of HK1040933A1 publication Critical patent/HK1040933A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK02102768.4A 1998-11-24 2002-04-12 N-取代的氮雜二環烷衍生物在治療中樞神經系統疾病中的應用 HK1040933A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854147A DE19854147A1 (de) 1998-11-24 1998-11-24 Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht
PCT/EP1999/008734 WO2000030639A1 (de) 1998-11-24 1999-11-12 Verwendung von n-substituierten azabicycloalkan-derivaten zur behandlung von erkrankungen des zentralen nervensystems

Publications (1)

Publication Number Publication Date
HK1040933A1 true HK1040933A1 (zh) 2002-06-28

Family

ID=7888824

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02102768.4A HK1040933A1 (zh) 1998-11-24 2002-04-12 N-取代的氮雜二環烷衍生物在治療中樞神經系統疾病中的應用

Country Status (21)

Country Link
EP (1) EP1133293A1 (zh)
JP (1) JP2002530333A (zh)
KR (1) KR20010080535A (zh)
CN (1) CN1328455A (zh)
AR (1) AR021502A1 (zh)
AU (1) AU1775300A (zh)
BG (1) BG105549A (zh)
BR (1) BR9915589A (zh)
CA (1) CA2352526A1 (zh)
CZ (1) CZ20011796A3 (zh)
DE (1) DE19854147A1 (zh)
HK (1) HK1040933A1 (zh)
HR (1) HRP20010472A2 (zh)
HU (1) HUP0104416A3 (zh)
IL (1) IL143181A0 (zh)
NO (1) NO20012538L (zh)
PL (1) PL348758A1 (zh)
SK (1) SK7112001A3 (zh)
TR (1) TR200101476T2 (zh)
WO (1) WO2000030639A1 (zh)
ZA (1) ZA200103976B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1836183A2 (en) 2004-12-13 2007-09-26 Galileo Pharmaceuticals, Inc. Spiro derivatives as lipoxygenase inhibitors
GB0812310D0 (en) 2008-07-03 2008-08-13 Syngenta Ltd Novel herbicides
EP2945637B1 (en) * 2013-01-15 2021-03-10 Novartis AG Use of alpha 7 nicotinic acetylcholine receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348460A4 (en) * 1987-11-12 1991-11-27 American Home Products Corporation Polycyclicamines with psychotropic activity
DE4427648A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
DE4427647A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
AU1775300A (en) 2000-06-13
CA2352526A1 (en) 2000-06-02
HUP0104416A2 (hu) 2002-04-29
BG105549A (en) 2001-12-29
WO2000030639A1 (de) 2000-06-02
HUP0104416A3 (en) 2002-11-28
CZ20011796A3 (cs) 2002-05-15
AR021502A1 (es) 2002-07-24
JP2002530333A (ja) 2002-09-17
EP1133293A1 (de) 2001-09-19
ZA200103976B (en) 2002-05-16
TR200101476T2 (tr) 2001-10-22
PL348758A1 (en) 2002-06-03
HRP20010472A2 (en) 2003-04-30
IL143181A0 (en) 2002-04-21
KR20010080535A (ko) 2001-08-22
SK7112001A3 (en) 2001-12-03
DE19854147A1 (de) 2000-05-25
BR9915589A (pt) 2001-08-07
NO20012538L (no) 2001-07-04
CN1328455A (zh) 2001-12-26
NO20012538D0 (no) 2001-05-23

Similar Documents

Publication Publication Date Title
AU8119001A (en) Hybrid neuroprosthesis for the treatment of brain disorders
IL133800A0 (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
EP1063990A4 (en) THERAPY FOR ESTROGEN RELATED DISORDERS
IL139591A0 (en) Combination therapy for treatment of bipolar disorders
HU9803018D0 (en) Methods and compositions for the treatment and prevention of tumors, tumor-veloted disorders and cachexia
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
IL141263A0 (en) Methods for treatment of neurological disorders
EP1207874A4 (en) METHOD FOR THE TREATMENT OF PROLIFERATIVE DISEASES
PL345769A1 (en) Triazolopyridines for the treatment of thrombosis disorders
EE200000391A (et) Triasiiniühendid kesknärvisüsteemihäirete raviks
HUP0101947A3 (en) Combination for the treatment of tumors
HK1038510B (zh) 使用神經營養因子興奮劑治療眼神經變性疾病
ATE256126T1 (de) 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
EP1181308A4 (en) METHODS OF TREATING NEURONAL DEMENTIA ASSOCIATED WITH ATROPHY
PL347329A1 (en) 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders
IL140540A0 (en) Treatment of anxiety disorders
HK1040933A1 (zh) N-取代的氮雜二環烷衍生物在治療中樞神經系統疾病中的應用
CZ20011872A3 (cs) Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny
HUP0100365A3 (en) Combination therapy for the treatment of aids
GR20010300072T1 (en) Use of effectors of the central cholinergic nervous system
PT1011678E (pt) Utilização de mecamilamina para o tratamento de perturbações neuropsiquiátricas responsivas à nicotina.
ZA985818B (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders.
GB0010496D0 (en) Treatment of conditions of the central nervous system
GB9821610D0 (en) Treatment of neuropsychiatric disorders